Point-of-care Diagnostics Market is expected to cross US$ 66 bn by the end of 2028, States TMR Study

Rise in the number of people living with diabetes, cardiovascular diseases, and cancer is creating business prospects in the North America market


ALBANY, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- A study by Transparency Market Research (TMR) states that the global point-of-care diagnostics market is prognosticated to expand at a CAGR of 4.7% during the forecast period from 2021 to 2028.

Government authorities of several nations around the world are providing favorable reimbursement policies pertaining to the healthcare. As a result, there has been rise in the adoption of various point-of-care diagnostics services in the recent years. Moreover, many developing nations around the world are investing heavily in the development of their healthcare infrastructure. This factor is creating sizable business prospects for players operating in the global point-of-care diagnostics market.

Request Brochure of Point-of-care Diagnostics Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1128

Point-of-care Diagnostics Market: Key Findings

  • In point-of-care diagnostics devices, a combination of biosensors is used. These devices are gaining traction, as they can assist in advancing the patient care services through remote as well as real-time health monitoring. Moreover, these techniques are being increasing adopted instead of the label-based techniques, which are lengthy and may result into several complexities. Hence, rise in the adoption of such diagnostics devices is propelling the growth of the point-of-care diagnostics market.
  • Point-of-care diagnostics are gaining immense popularity among healthcare professionals from across the globe as these devices offer precise, trustworthy, high-quality, and real-time outcomes in a short time. Hence, these diagnostics assist clinicians, physicians, and other healthcare professionals while making quick and precise decisions pertaining to the treatment plan of a patient, notes a TMR study on the global point-of-care diagnostics market. Owing to these factors, the market for point-of-care diagnostics is expected to gain a valuation of US$ 66 Bn by 2028.

Request for Analysis of COVID-19 Impact on Point-of-care Diagnostics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1128

Point-of-care Diagnostics Market: Growth Boosters

  • Rise in use of home healthcare services globally is driving sales in the point-of-care diagnostics market
  • Increase in prevalence of different transmittable diseases, including malaria and HIV/AIDS is driving demand opportunities in the point-of-care diagnostics market

Point-of-care Diagnostics Market: Regional Analysis

  • The point-of-care diagnostics market in North America is prognosticated to maintain its prominent position in the forthcoming years, owing to many factors such as surge in the cases of diabetes, cardiovascular diseases, & cancer, and increase in geriatric population in the region
  • The Asia Pacific point-of-care diagnostics market is expected to grow during the forecast period, owing to factors such as increase in regional governments’ initiatives to offer superior healthcare facilities, rise in population, and surge in prevalence of different viral diseases. Moreover, the point-of-care diagnostics market in Asia Pacific is estimated to gain lucrative opportunities due to improving spending power of the regional populace.

Get Exclusive PDF Sample Copy of Point-of-care Diagnostics Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1128

Point-of-care Diagnostics Market: Competition Landscape

  • Companies operating in the point-of-care diagnostics market are increasing their investments in R&Ds in order to develop technologically advanced products. Such initiatives are helping companies in new product launches, thereby strengthening their product portfolios.
  • Several prominent players operating in the point-of-care diagnostics market are using different strategies such as joint ventures, partnerships, and mergers & acquisitions in order to maintain their position. In addition, such strategies are also helping companies in the point-of-care diagnostics market to boost their production abilities and expand in new regions.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1128

Point-of-care Diagnostics Market: Key Players

Some of the key players profiled in the report are:

  • bioMérieux SA
  • Johnson & Johnson Services, Inc.
  • Nova Biomedical
  • F. Hoffmann-La Roche Ltd.
  • Bio Rad Laboratories, Inc.
  • Siemens AG
  • Danaher Corporation
  • Abbott
  • Thermo Fisher Scientific, Inc
  • Cardinal Health Inc

Point-of-care Diagnostics Market Segmentation

Platform        

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Others

Application        

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Pregnancy & Fertility Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-abuse Testing Products
  • Others

End-user        

  • Hospitals
  • Diagnostic Laboratories
  • Clinics / Physician Offices
  • Home Care
  • Others

Region        

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Point-of-care UTI Devices Market: Urinary tract infection (UTI) is one of the most common types of bladder infections that affects many people globally. Urinary tract infection occurs when bacteria enter the urinary tract through the urethra and start to multiply in the bladder. This results in swelling, pain, and redness in the urinary tract. According to the National Kidney Foundation, urinary tract infection is the second most common infection among women.

Point-of-Care Clinical Chemistry Market: Point-of-care chemistry refers to as a number of tests such as Na, Cl, Mg, urea, creatinine, TCO2, iCa, Hct, and hemoglobin, which are included in a variety of combination. Clinical chemistry tests/panels are a group of test performed to determine the health status of an individual. These tests are performed majorly to evaluate a body’s electrolyte balance and to check status (health) of the organs.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/care-diagnostics-market.htm